Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 CAD | -5.00% | -1.72% | -16.18% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 |
---|---|---|---|
Capitalization 1 | 59.54 | 44.48 | 40.28 |
Enterprise Value (EV) 1 | 57.7 | 43.87 | 40.36 |
P/E ratio | -16.2 x | -19.8 x | -10.8 x |
Yield | - | - | - |
Capitalization / Revenue | - | - | - |
EV / Revenue | - | - | - |
EV / EBITDA | -30.2 x | -21.5 x | -11.6 x |
EV / FCF | 3,220,140,410 x | -55,419,529 x | -28,222,629 x |
FCF Yield | 0% | -0% | -0% |
Price to Book | 31.5 x | 53.1 x | 442 x |
Nbr of stocks (in thousands) | 108,263 | 111,192 | 118,466 |
Reference price 2 | 0.5500 | 0.4000 | 0.3400 |
Announcement Date | 5/2/22 | 4/25/23 | 4/10/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales | - | - | - | - | - | - |
EBITDA 1 | -0.0371 | -0.0118 | -0.0994 | -1.912 | -2.038 | -3.488 |
EBIT 1 | -0.0977 | -0.0786 | -0.1725 | -2.008 | -2.14 | -3.606 |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.0977 | -0.0786 | -0.1725 | -3.515 | -2.22 | -3.644 |
Net income 1 | -0.0977 | -0.0786 | -0.1725 | -3.515 | -2.22 | -3.644 |
Net margin | - | - | - | - | - | - |
EPS 2 | -0.004401 | -0.003542 | -0.0100 | -0.0339 | -0.0202 | -0.0316 |
Free Cash Flow | - | 0.1166 | -0.4114 | 0.0179 | -0.7917 | -1.43 |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/23/21 | 7/23/21 | 7/23/21 | 5/2/22 | 4/25/23 | 4/10/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 0.09 |
Net Cash position 1 | 0 | 0 | 0 | 1.84 | 0.6 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -0.0246 x |
Free Cash Flow | - | 0.12 | -0.41 | 0.02 | -0.79 | -1.43 |
ROE (net income / shareholders' equity) | - | -70.8% | -2,784% | 363% | -150% | -785% |
ROA (Net income/ Total Assets) | - | -7.9% | -17.8% | -52.1% | -66.4% | -187% |
Assets 1 | - | 0.9961 | 0.9715 | 6.748 | 3.342 | 1.948 |
Book Value Per Share 2 | -0.0100 | -0.0100 | -0.0200 | 0.0200 | 0.0100 | 0 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0.0200 | 0.0100 | 0 |
Capex | - | - | - | - | - | 0.08 |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 7/23/21 | 7/23/21 | 7/23/21 | 5/2/22 | 4/25/23 | 4/10/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-16.18% | 25.07M | |
+8.63% | 7.99B | |
-5.94% | 4.63B | |
+3.70% | 3.25B | |
+12.70% | 2.26B | |
+10.07% | 1.03B | |
-37.02% | 959M | |
+1.44% | 888M | |
-29.34% | 693M | |
-58.26% | 660M |
- Stock Market
- Equities
- OTC Stock
- Financials Ocumetics Technology Corp.